Telangana Aims for Hyderabad to Lead Life Sciences Hub with Biopharma SHAKTI Boost

• Telangana targets Hyderabad as a premier life sciences hub, leveraging the Centre's Biopharma SHAKTI initiative.
• The state contributes nearly 35% of India's pharmaceutical production and hosts over 2,000 life sciences companies.
• Telangana's 'Next-Gen Life Sciences Policy 2026-2030' aligns with Biopharma SHAKTI, focusing on biologics and biosimilars.
• Chief Minister A Revanth Reddy inaugurated BioAsia 2026, inviting biopharma companies to establish Global Capability Centres (GCCs) in Hyderabad.
• The Centre allocated Rs 10,000 crore for Biopharma SHAKTI to position India as a global biopharma manufacturing hub.